CARTEOL L.P. 2 %, eye drops with extended release in a single-dose container 30 single-dose containers of 0.2 ml
Active ingredients: Carteolol hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Eye drops with extended release30 single-dose containers of 0.2 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CARTEOL L.P. 2 %, collyre à libération prolongée en récipient unidose
- Pharmaceutical form
- collyre à libération prolongée
- Route of administration
- ophtalmique
- Presentation description
- 30 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 0,2 ml
- Marketing authorisation holder
- LABORATOIRE CHAUVIN
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Apr 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68530585CIP73600901CIP133400936009011Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE CARTÉOLOLcollyre | 4 mg · un récipient unidose de 0,2 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.